Company intelligence / Profile preview

Salus Alba

Glasgow, Scotland, United Kingdomsalusalba.com ↗

Ownership: Private
Employees: ~28
Development stage: Other

Overview

Salus Alba is a UK-based consultancy specializing in supporting pharmaceutical companies with Health Technology Assessment (HTA) submissions, evidence generation and synthesis, systematic literature reviews, health economics assessments, economic modeling, and knowledge management. They also provide tailored training for pharma clients on HTA processes and market access strategies. The firm is led by Dr. Andrew Walker, an expert in health economics and HTA who also advises NICE's Early Scientific Advice Service[1][2][3].

Industry: Consulting

Partnerships

Collaborates with pharmaceutical companies seeking market access or reimbursement for their products via HTA submissions to agencies such as NICE and SMC

Beyond the preview

Go deeper on Salus Alba.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salus Alba.

Explore the full profile